Barclays PLC Psychemedics Corp Transaction History
Barclays PLC
- $327 Billion
- Q2 2024
Shares
4 transactions
Others Institutions Holding PMD
# of Institutions
25Shares Held
1.19MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA274KShares$639,3930.77% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny257KShares$598,7230.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA251KShares$585,4890.0% of portfolio
-
Rbf Capital, LLC San Francisco, CA142KShares$331,1900.02% of portfolio
-
Black Rock Inc. New York, NY71KShares$165,4740.0% of portfolio
About PSYCHEMEDICS CORP
- Ticker PMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 5,626,200
- Market Cap $13.1M
- Description
- Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, ...